Search

Your search keyword '"Brock, Marko"' showing total 175 results
Start Over Author "Brock, Marko"
175 results on '"Brock, Marko"'

1. Harninkontinenz nach radikaler Prostatektomie beim Prostatakarzinom – aktuelle Daten von 17.149 Patienten aus 125 zertifizierten Zentren

Author

Kowalski, Christoph, Sibert, Nora Tabea, Hammerer, Peter, Wesselmann, Simone, Feick, Günter, Carl, Ernst-Günther, Klotz, Theodor, Apel, Hendrik, Dieng, Sebastian, Nyarangi-Dix, Joanne, Knoll, Thomas, Reike, Moritz Johannes, Duwe, Gregor, Bartolf, Elisabeth, Steiner, Thomas, Borowitz, Rainer, Lümmen, Gerd, Seitz, Anna Katharina, Pfitzenmaier, Jesco, Aziz, Atiqullah, Brock, Marko, Berger, Frank Peter, Kaftan, Björn Theodor, Grube, Christian, Häfner, Tim, Hamza, Amir, Schmelz, Hans, Haas, Jürgen, Lenart, Sebastian, Lafita, Anselm, Sippel, Carsten, Winter, Alexander, Kedia, George, Hadaschik, Boris, Varga, Zoltan, Buse, Stephan, Richter, Matthias, Distler, Florian, Simon, Jörg, Wiegel, Thomas, Baltes, Stefan, Janitzky, Andreas, Sommer, Jens Peter, Hijazi, Sameh, Fülkell, Philipp, Harke, Nina N., Bolenz, Christian, Khalil, Christian, Breidenbach, Clara, Tennstedt, Pierre, and Burchardt, Martin

Published
2024
Full Text
View/download PDF

2. Predictors for the utilization of social service counseling by prostate cancer patients

Author

Breidenbach, Clara, Ansmann, Lena, Sibert, Nora Tabea, Wesselmann, Simone, Dieng, Sebastian, Carl, Ernst-Günther, Feick, Günter, Stoklossa, Cindy, Taubert, Anne, Pomery, Amanda, Beyer, Burkhard, Blana, Andreas, Brock, Marko, Distler, Florian, Enge, Michael, Gaber, Amr A., Gilfrich, Christian, Hinkel, Andreas, Kaftan, Björn, Knoll, Thomas, Kunath, Frank, Oostdam, Simba-Joshua, Peters, Inga, Polat, Bülent, Schrodi, Valentin, Zengerling, Friedemann, and Kowalski, Christoph

Published
2022
Full Text
View/download PDF

4. Harninkontinenz nach radikaler Prostatektomie beim Prostatakarzinom – aktuelle Daten von 17.149 Patienten aus 125 zertifizierten Zentren

Author

Kowalski, Christoph, primary, Sibert, Nora Tabea, additional, Hammerer, Peter, additional, Wesselmann, Simone, additional, Feick, Günter, additional, Carl, Ernst-Günther, additional, Klotz, Theodor, additional, Apel, Hendrik, additional, Dieng, Sebastian, additional, Nyarangi-Dix, Joanne, additional, Knoll, Thomas, additional, Reike, Moritz Johannes, additional, Duwe, Gregor, additional, Bartolf, Elisabeth, additional, Steiner, Thomas, additional, Borowitz, Rainer, additional, Lümmen, Gerd, additional, Seitz, Anna Katharina, additional, Pfitzenmaier, Jesco, additional, Aziz, Atiqullah, additional, Brock, Marko, additional, Berger, Frank Peter, additional, Kaftan, Björn Theodor, additional, Grube, Christian, additional, Häfner, Tim, additional, Hamza, Amir, additional, Schmelz, Hans, additional, Haas, Jürgen, additional, Lenart, Sebastian, additional, Lafita, Anselm, additional, Sippel, Carsten, additional, Winter, Alexander, additional, Kedia, George, additional, Hadaschik, Boris, additional, Varga, Zoltan, additional, Buse, Stephan, additional, Richter, Matthias, additional, Distler, Florian, additional, Simon, Jörg, additional, Wiegel, Thomas, additional, Baltes, Stefan, additional, Janitzky, Andreas, additional, Sommer, Jens Peter, additional, Hijazi, Sameh, additional, Fülkell, Philipp, additional, Harke, Nina N., additional, Bolenz, Christian, additional, Khalil, Christian, additional, Breidenbach, Clara, additional, Tennstedt, Pierre, additional, and Burchardt, Martin, additional

Published
2023
Full Text
View/download PDF

7. A multicenter paper-based and web-based system for collecting patient-reported outcome measures in patients undergoing local treatment for prostate cancer: first experiences

Author

Kowalski, Christoph, Roth, Rebecca, Carl, Günther, Feick, Günter, Oesterle, Alisa, Hinkel, Andreas, Steiner, Thomas, Brock, Marko, Kaftan, Björn, Borowitz, Rainer, Zantl, Niko, Heidenreich, Axel, Neisius, Andreas, Darr, Christopher, Bolenz, Christian, Beyer, Burkhard, Pfitzenmaier, Jesco, Brehmer, Bernhard, Fichtner, Jan, Haben, Björn, Wesselmann, Simone, and Dieng, Sebastian

Published
2020
Full Text
View/download PDF

8. Prediction models of incontinence and sexual function one year after radical prostatectomy based on data from 20 164 prostate cancer patients.

Author

Sibert, Nora Tabea, Kurth, Tobias, Breidenbach, Clara, Wesselmann, Simone, Feick, Günther, Carl, Ernst-Günter, Dieng, Sebastian, Albarghouth, Mohamad Hatem, Aziz, Atiqullah, Baltes, Stefan, Bartolf, Elisabeth, Bedke, Jens, Blana, Andreas, Brock, Marko, Conrad, Stefan, Darr, Christopher, Distler, Florian, Drosos, Konstantinos, Duwe, Gregor, and Gaber, Amr

Subjects
PROSTATE cancer patients, RADICAL prostatectomy, PREDICTION models, PROGNOSTIC models, IMPOTENCE
Abstract

Background: Incontinence and sexual dysfunction are long-lasting side effects after surgical treatment (radical prostatectomy, RP) of prostate cancer (PC). For an informed treatment decision, physicians and patients should discuss expected impairments. Therefore, this paper firstly aims to develop and validate prognostic models that predict incontinence and sexual function of PC patients one year after RP and secondly to provide an online decision making tool. Methods: Observational cohorts of PC patients treated between July 2016 and March 2021 in Germany were used. Models to predict functional outcomes one year after RP measured by the EPIC-26 questionnaire were developed using lasso regression, 80–20 splitting of the data set and 10-fold cross validation. To assess performance, R2, RMSE, analysis of residuals and calibration-in-the-large were applied. Final models were externally temporally validated. Additionally, percentages of functional impairment (pad use for incontinence and firmness of erection for sexual score) per score decile were calculated to be used together with the prediction models. Results: For model development and internal as well as external validation, samples of 11 355 and 8 809 patients were analysed. Results from the internal validation (incontinence: R2 = 0.12, RMSE = 25.40, sexual function: R2 = 0.23, RMSE = 21.44) were comparable with those of the external validation. Residual analysis and calibration-in-the-large showed good results. The prediction tool is freely accessible: https://nora-tabea.shinyapps.io/EPIC-26-Prediction/. Conclusion: The final models showed appropriate predictive properties and can be used together with the calculated risks for specific functional impairments. Main strengths are the large study sample (> 20 000) and the inclusion of an external validation. The models incorporate meaningful and clinically available predictors ensuring an easy implementation. All predictions are displayed together with risks of frequent impairments such as pad use or erectile dysfunction such that the developed online tool provides a detailed and informative overview for clinicians as well as patients. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

12. Ist es klinisch und onkologisch sicher, bei Patienten mit einer niedrig-Risiko-Stratifikation auf eine Prostatabiopsie zu verzichten?

Author

Bahlburg, Henning, Tully, Karl, Hoffmann, Vincent, Hanske, Julian, Roghmann, Florian, von Landenberg, Nicolas, Palisaar, Rein-J��ri, Noldus, Joachim, Berg, Sebastian, and Brock, Marko

Subjects
ddc: 610, Medicine and health
Abstract

Einleitung: Gem���� den aktuellen Leitlinien soll vor einer Prostatabiopsie zun��chst eine individuelle Risikokalkulation erfolgen. Anhand des risk-stratified pathway (RSP) sollen sowohl Prostatabiopsien als auch m��gliche Komplikationen nach Biopsie und eine ��berdiagnose von klinisch [zum vollst��ndigen Text gelangen Sie ��ber die oben angegebene URL]

Published
2022

15. How many cores should be sampled during systematic prostate biopsy in case of negative multiparametric magnetic resonance imaging?

Author

Berg, Sebastian (Dr. med.), Tully, Karl Heinrich (Dr. med.), Landenberg, Nicolas von (Dr. med.), Bahlburg, Henning Matthias (D. med.), Roghmann, Florian (PD Dr. med.), Müller, Guido (Dr. med.), Hanske, Julian, Noldus, Joachim (Prof. Dr. med.), and Brock, Marko (PD Dr. med.)

Subjects
ddc:610
Abstract

\(\bf Introduction:\) This study aimed to investigate the number of cores needed in a systematic biopsy (SB) in men with clinical suspicion of prostate cancer (PCa) but negative prebiopsy multiparametric magnetic resonance imaging and to test prostate-specific antigen (PSA) density as an indicator for reduced SB. \(\bf Methods:\) Two hundred and seventy-four patients were analyzed, extracted from an institutional database. Detection rates of any PCa and clinically significant (CS) PCa for different reduced biopsy protocols were compared by using Fisher’s exact test. \(\bf Results:\) In total, 12-core SB revealed PCa in 103 (37.6%) men. Detection rates of reduced biopsy protocols were 74 (27%, 6-core) and 82 (29.9%, 8-core). Regarding CSPCa, 12-core SB revealed a detection rate of 26 (9.5%). Reduced biopsy protocols detected less CSPCa: 15 (5.5%) and 18 (6.6%), respectively. All differences were statistically significant, \(\it p\) < 0.05. PSA density \(\geq\)0.15 did not help to filter out men in whom a reduced biopsy may be sufficient. \(\bf Conclusions:\) Twelve-core SB still has the highest detection rate of any PCa and CSPCa compared to reduced biopsy protocols. If the investigator and patient agree – based on individual risk calculation – to perform a biopsy, this SB should contain at least 12 cores regardless of PSA density.

Published
2021

16. How Many Cores Should Be Sampled during Systematic Prostate Biopsy in Case of Negative Multiparametric Magnetic Resonance Imaging? Analysis of 274 Men with Clinical Suspicion of Prostate Cancer

Author

Berg, Sebastian, primary, Tully, Karl Heinrich, additional, von Landenberg, Nicolas, additional, Bahlburg, Henning, additional, Roghmann, Florian, additional, Müller, Guido, additional, Hanske, Julian, additional, Noldus, Joachim, additional, and Brock, Marko, additional

Published
2021
Full Text
View/download PDF

17. Predictors for the utilization of social service counseling by prostate cancer patients

Author

Breidenbach, Clara, primary, Ansmann, Lena, additional, Sibert, Nora Tabea, additional, Wesselmann, Simone, additional, Dieng, Sebastian, additional, Carl, Ernst-Günther, additional, Feick, Günter, additional, Stoklossa, Cindy, additional, Taubert, Anne, additional, Pomery, Amanda, additional, Beyer, Burkhard, additional, Blana, Andreas, additional, Brock, Marko, additional, Distler, Florian, additional, Enge, Michael, additional, Gaber, Amr A., additional, Gilfrich, Christian, additional, Hinkel, Andreas, additional, Kaftan, Björn, additional, Knoll, Thomas, additional, Kunath, Frank, additional, Oostdam, Simba-Joshua, additional, Peters, Inga, additional, Polat, Bülent, additional, Schrodi, Valentin, additional, Zengerling, Friedemann, additional, and Kowalski, Christoph, additional

Published
2021
Full Text
View/download PDF

25. Probability of prostate cancer diagnosis following negative systematic and targeted MRI: transrectal ultrasound fusion biopsy

Author

Landenberg, Nicolas von (Dr. med.), Hanske, Julian, Noldus, Joachim (Prof. Dr. med.), Roghmann, Florian (PD Dr. med.), Tully, Karl Heinrich (Dr. med.), Wald, Jan, Berg, Sebastian (Dr. med.), and Brock, Marko (PD Dr. med.)

Subjects
ddc:610
Abstract

\(\bf Introduction:\) The risk of occult prostate carcinoma (PCa) after negative multiparametric MRI (mpMRI)-transrectal fusion biopsy (F-Bx) is unknown. To determine the false-negative predictive value, we examined PCa detection after prior negative F-Bx. \(\bf Methods:\) Between December 2012 and November 2016, 491 patients with suspected PCa and suspicious mpMRI findings underwent transrectal F-Bx. Patients with benign pathology (\(\it n\) = 191) were eligible for our follow-up (FU) survey. Patient characteristics and clinical parameters were correlated to subsequent findings of newly detected PCa. \(\bf Results:\) Complete FU with a median of 31 (interquartile range: 17–39) months was available for 176/191 (92.2%) patients. Of those, 54 men had either surgical interventions on the prostate or re-Bxs. Newly detected PCa was evident in 14/176 (7.95%) patients stratified to ISUP \(\leq\) 2 in 10 and \(\geq\) 3 in 4 cases. The comparison of patients with newly detected PCa to those without cancerous findings in FU showed significant differences in prostate-specific antigen (PSA) density (0.16 vs. 0.13 ng/mL\(^{2}\)) and prostate volume (45 vs. 67 mL, both \(\it p\) < 0.05). Both factors are significant predictors for newly detected cancer after initial negative F-Bx. \(\bf Conclusion:\) Only PSA density (>0.13 ng/mL\(^{2}\)) and small prostate volume are significant predictors for newly detected PCa after initial negative F-Bx. Despite negative mpMRI/TRUS F-Bx results, patients should be further monitored due to a risk of developing PCa over time. Notwithstanding the limitation of our study that not all patients underwent another Bx, we assume that the false-negative rate is low but existing. Our data represent a real-world scenario.

Published
2021

26. How Many Cores Should Be Sampled during Systematic Prostate Biopsy in Case of Negative Multiparametric Magnetic Resonance Imaging? Analysis of 274 Men with Clinical Suspicion of Prostate Cancer.

Author

Berg, Sebastian, Tully, Karl Heinrich, von Landenberg, Nicolas, Bahlburg, Henning, Roghmann, Florian, Müller, Guido, Hanske, Julian, Noldus, Joachim, and Brock, Marko

Subjects
PROSTATE biopsy, MAGNETIC resonance imaging, PROSTATE cancer, STATISTICAL sampling, FISHER exact test, PROSTATE-specific antigen
Abstract

Introduction: This study aimed to investigate the number of cores needed in a systematic biopsy (SB) in men with clinical suspicion of prostate cancer (PCa) but negative prebiopsy multiparametric magnetic resonance imaging and to test prostate-specific antigen (PSA) density as an indicator for reduced SB. Methods: Two hundred and seventy-four patients were analyzed, extracted from an institutional database. Detection rates of any PCa and clinically significant (CS) PCa for different reduced biopsy protocols were compared by using Fisher's exact test. Results: In total, 12-core SB revealed PCa in 103 (37.6%) men. Detection rates of reduced biopsy protocols were 74 (27%, 6-core) and 82 (29.9%, 8-core). Regarding CSPCa, 12-core SB revealed a detection rate of 26 (9.5%). Reduced biopsy protocols detected less CSPCa: 15 (5.5%) and 18 (6.6%), respectively. All differences were statistically significant, p < 0.05. PSA density ≥0.15 did not help to filter out men in whom a reduced biopsy may be sufficient. Conclusions: Twelve-core SB still has the highest detection rate of any PCa and CSPCa compared to reduced biopsy protocols. If the investigator and patient agree – based on individual risk calculation – to perform a biopsy, this SB should contain at least 12 cores regardless of PSA density. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

27. Psychosocial Distress in the Early Recovery Period after Radical Prostatectomy.

Author

Kozaris, Raphael, Hanske, Julian, von Landenberg, Nicolas, Berg, Sebastian, Roghmann, Florian, Brock, Marko, Noldus, Joachim, and Müller, Guido

Subjects
PSYCHOLOGICAL distress, RADICAL prostatectomy, OLDER patients, LOGISTIC regression analysis, TUMOR classification
Abstract

Purpose: This study aimed to evaluate psychosocial distress in the context of continence and oncological outcome during the early recovery period after radical prostatectomy (RP) for prostate cancer. Patients and Methods: Retrospectively collected data from 587 patients who underwent inpatient rehabilitation after RP in 2016 and 2017 were analyzed. Psychosocial distress (measured by using a Questionnaire on Stress in Cancer Patients [QSC-R10]) and continence status (urine loss on a 24-h pad test and urine volume on uroflowmetry) were evaluated at the beginning (T1) and end (T2) of a 3-week inpatient rehabilitation. Multivariate logistic regression was performed to identify predictors for high distress (QSC-R10 score ≥15). Results: The median patient age was 65 years. At the start of rehabilitation, 204 patients (34.8%) demonstrated high distress. Psychosocial distress decreased significantly (p < 0.001) from a median of 11.0 at T1 (median 16 days after surgery) to a median of 6.0 at T2 (median 37 days after surgery). Complete continence increased significantly (p < 0.001) from 39.0% at T1 to 58.9% at T2. The median urine volume increased significantly (p < 0.001) from 161 mL at T1 to 230 mL at T2. Often, distress is higher in younger patients, whereas incontinence is higher in older patients. Multivariate logistic regression analysis identified age ≤69 years (p = 0.001) and tumor stage ≥pT3 (p = 0.006) as independent predictors of high distress. Conclusions: Distress and incontinence decreased significantly during the 3 weeks of inpatient rehabilitation after RP. Patient age ≤69 years and tumor stage ≥pT3 are independent predictors of high psychosocial distress. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

28. Identification of patients at risk for biochemical recurrence after radical prostatectomy with intra‐operative frozen section

Author

Tully, Karl H., primary, Schulmeyer, Max, additional, Hanske, Julian, additional, Reike, Moritz J., additional, Brock, Marko, additional, Moritz, Rudolf, additional, Jütte, Hendrik, additional, Tannapfel, Andrea, additional, Bodman, Christian, additional, Noldus, Joachim, additional, Palisaar, Rein‐Jüri, additional, and Roghmann, Florian, additional

Published
2021
Full Text
View/download PDF

32. Präoperative Prädiktoren für intraoperativen Nerverhalt bei Radikaler Prostatektomie

Author

Tully, Karl, Moritz, Rudolf, Schulmeyer, Maximilian, Reike, Moritz, Hanske, Julian, von Landenberg, Nicolas, Brock, Marko, Jütte, Hendrik, von Bodman, Christian, Noldus, Joachim, Roghmann, Florian, and Palisaar, Rein-Jüri

Subjects
ddc: 610, 610 Medical sciences, Medicine
Abstract

Einleitung: Das funktionelle Ergebnis nach radikaler Prostatektomie ist ein postoperatives Qualitätsmerkmal. Ein entscheidender Faktor für ein suffizientes funktionelles Ergebnis ist der bilaterale Erhalt des neurovaskulären Bündels. Ziel dieser Arbeit ist die Evaluation präoperative[zum vollständigen Text gelangen Sie über die oben angegebene URL], 66. Kongress der Nordrhein-Westfälischen Gesellschaft für Urologie

Published
2020

33. Einfluss residualer Tumorzellen im Nachresektat nach positivem intraoperativem Schnellschnitt auf das biochemische Rezidiv infolge einer radikalen Prostatektomie

Author

Tully, Karl, Schulmeyer, Maximilian, Reike, Moritz, Hanske, Julian, von Landenberg, Nicolas, Moritz, Rudolf, Brock, Marko, Jütte, Hendrik, von Bodman, Christian, Noldus, Joachim, Roghmann, Florian, and Palisaar, Rein-Jüri

Subjects
ddc: 610, 610 Medical sciences, Medicine
Abstract

Einleitung: Ein positiver Resektionsstatus (R+) nach radikaler Prostatektomie geht mit einem schlechteren rezidivfreien und krankheitsspezifischen Überleben einher. Eine Möglichkeit zur Reduktion der R+-Raten ist die Durchführung einer intraoperativen Schnellschnittuntersuchung[zum vollständigen Text gelangen Sie über die oben angegebene URL], 66. Kongress der Nordrhein-Westfälischen Gesellschaft für Urologie

Published
2020
Full Text
View/download PDF

34. Onkologische und funktionelle Ergebnisse nach MRT/TRUS fusionsgesteuerter HIFU-Therapie beim lokal begrenzten Prostatakarzinom

Author

Hanske, Julian, Roghmann, Florian, Noldus, Joachim, Tully, Karl, von Landenberg, Nicolas, Berg, Sebastian, and Brock, Marko

Subjects
ddc: 610, 610 Medical sciences, Medicine
Abstract

Einleitung: Der hochintensive fokussierte Ultraschall (HIFU) kann eine Therapieoption des lokal begrenzten Prostatakarzinoms (PCa) sein. Ganzdrüsen- bzw. Halbseiten-Ablation finden häufig Anwendung. Eine fokale HIFU-Therapie basierend auf den Ergebnissen einer elastischen MRT/TRUS Fusionsbiopsie[zum vollständigen Text gelangen Sie über die oben angegebene URL], 66. Kongress der Nordrhein-Westfälischen Gesellschaft für Urologie

Published
2020
Full Text
View/download PDF

35. Institutional adoption and apprenticeship of fusion targeted prostate biopsy

Author

Berg, Sebastian (Dr. med.), Hanske, Julian, Landenberg, Nicolas von (Dr. med.), Noldus, Joachim (Prof. Dr. med.), and Brock, Marko (PD Dr. med.)

Subjects
urologic and male genital diseases
Abstract

\(\textit {Introduction:}\) There are limited data on the learning curve of magnetic resonance imaging/transrectal ultrasound (MRI/TRUS)-fusion targeted prostate biopsies (tBx). \(\textit {Objective:}\) The aim of this study was to investigate the difference in prostate cancer (PCa) detection rate between an experienced urologist and novice resident performing tBx. \(\textit {Methods:}\) A total of 183 patients underwent tBx from 2012 to 2016 for a total of 518 tBx cores. Biopsies in this study were performed by an experienced urologist (investigator A) or a novice resident (investigator B). The outcome was the detection of PCa on tBx. Using a multivariable logistic regression model, we estimated odds ratios for the detection of PCa. Inverse probability treatment weighting (IPTW) was used to balance patients' baseline characteristics and compare detection rates of PCa. Before performance of tBx, all patients underwent MRI. \(\textit {Results:}\) On multivariable logistic regression analysis, investigator experience was associated with a higher odds of detection of PCa (OR = 1.003; 95% confidence interval 1.002–1.006, \(\it p\) = 0.037). After IPTW adjustment, there was no significant difference between the detection rate of investigator A (23%) and investigator B (32%; \(\it p\) = 0.457). \(\textit {Conclusions:}\) Data revealed a positive association between investigator experience and the odds of PCa detection, although there was no difference in the detection rates of the investigators.

Published
2020

36. Additional file 1 of A multicenter paper-based and web-based system for collecting patient-reported outcome measures in patients undergoing local treatment for prostate cancer: first experiences

Author

Kowalski, Christoph, Roth, Rebecca, Carl, Günther, Feick, Günter, Oesterle, Alisa, Hinkel, Andreas, Steiner, Thomas, Brock, Marko, Kaftan, Björn, Borowitz, Rainer, Zantl, Niko, Heidenreich, Axel, Neisius, Andreas, Darr, Christopher, Bolenz, Christian, Beyer, Burkhard, Jesco Pfitzenmaier, Brehmer, Bernhard, Fichtner, Jan, Haben, Björn, Wesselmann, Simone, and Dieng, Sebastian

Abstract

Additional file 1: Table 1. Patient recruitment relative to center according to treatment (for patients recruited in 2017).

Published
2020
Full Text
View/download PDF

44. Salvage lymph node dissection in hormone-naïve men: How effective is surgery?

Author

Hanske, Julian, primary, Ostholt, Jessica, additional, Roghmann, Florian, additional, Müller, Guido, additional, Braun, Katharina, additional, Gomez, Benedikt, additional, von Landenberg, Nicolas, additional, von Bodman, Christian, additional, Palisaar, Rein-Jüri, additional, Liermann, Dieter, additional, Noldus, Joachim, additional, and Brock, Marko, additional

Published
2019
Full Text
View/download PDF

45. Interdisciplinary Comparison of PADUA and R.E.N.A.L. Scoring Systems for Prediction of Conversion to Nephrectomy in Patients with Renal Mass Scheduled for Nephron Sparing Surgery

Author

Dahlkamp, Lisa, primary, Haeuser, Lorine, additional, Winnekendonk, Guido, additional, von Bodman, Christian, additional, Frey, Ulrich H., additional, Epplen, Robin, additional, Palisaar, Rein-Jueri, additional, Bach, Peter, additional, Noldus, Joachim, additional, Brock, Marko, additional, and Roghmann, Florian, additional

Published
2019
Full Text
View/download PDF

46. Reply by Authors

Author

Dahlkamp, Lisa, primary, Haeuser, Lorine, additional, Winnekendonk, Guido, additional, von Bodman, Christian, additional, Frey, Ulrich H., additional, Epplen, Robin, additional, Palisaar, Rein-Jueri, additional, Bach, Peter, additional, Noldus, Joachim, additional, Brock, Marko, additional, and Roghmann, Florian, additional

Published
2019
Full Text
View/download PDF

49. The EFSUMB Guidelines and Recommendations for the Clinical Practice of Elastography in Non-Hepatic Applications: Update 2018

Author

Săftoiu, Adrian, additional, Gilja, Odd Helge, additional, Sidhu, Paul S., additional, Dietrich, Christoph F., additional, Cantisani, Vito, additional, Amy, Dominique, additional, Bachmann-Nielsen, Michael, additional, Bob, Flaviu, additional, Bojunga, Jörg, additional, Brock, Marko, additional, Calliada, Fabrizio, additional, Clevert, Dirk André, additional, Correas, Jean-Michel, additional, D’Onofrio, Mirko, additional, Ewertsen, Caroline, additional, Farrokh, André, additional, Fodor, Daniela, additional, Fusaroli, Pietro, additional, Havre, Roald Flesland, additional, Hocke, Michael, additional, Ignee, André, additional, Jenssen, Christian, additional, Klauser, Andrea Sabine, additional, Kollmann, Christian, additional, Radzina, Maija, additional, Ramnarine, Kumar V., additional, Sconfienza, Luca Maria, additional, Solomon, Carolina, additional, Sporea, Ioan, additional, Ștefănescu, Horia, additional, Tanter, Mickael, additional, and Vilmann, Peter, additional

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results